Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SAKAI, Kazuko")

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathwaySAKAI, Kazuko; YOKOTE, Hideyuki; MURAKAMI-MUROFUSHI, Kimiko et al.Cancer science. 2007, Vol 98, Num 9, pp 1498-1503, issn 1347-9032, 6 p.Article

Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In VivoKUDO, Kanae; ARAO, Tokuzo; DE VELASCO, Marco A et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1373-1381, issn 1078-0432, 9 p.Article

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor GrowthKANEDA, Hiroyasu; ARAO, Tokuzo; YAMADA, Yasuhide et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 5, pp 2053-2063, issn 0008-5472, 11 p.Article

Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK―Positive Non―Small Cell Lung CancerTANIZAKI, Junko; OKAMOTO, Isamu; HATASHITA, Erina et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6219-6226, issn 1078-0432, 8 p.Article

Acquired Drug Resistance to Vascular Endothelial Growth Factor Receptor 2 Tyrosine Kinase Inhibitor in Human Vascular Endothelial CellsARAO, Tokuzo; MATSUMOTO, Kazuko; KOIZUMI, Fumiaki et al.Anticancer research. 2011, Vol 31, Num 9, pp 2787-2796, issn 0250-7005, 10 p.Article

Clinical Outcomes of Thoracic Radiotherapy for Locally Advanced NSCLC with EGFR Mutations or EML4-ALK RearrangementHAYASHI, Hidetoshi; OKAMOTO, Isamu; KIMURA, Hideharu et al.Anticancer research. 2012, Vol 32, Num 10, pp 4533-4537, issn 0250-7005, 5 p.Article

Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non―Small Cell Lung AdenocarcinomaKASAHARA, Kazuo; ARAO, Tokuzo; IKEDA, Norihiko et al.Clinical cancer research (Print). 2010, Vol 16, Num 18, pp 4616-4624, issn 1078-0432, 9 p.Article

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptorKIMURA, Hideharu; SAKAI, Kazuko; ARAO, Tokuzo et al.Cancer science. 2007, Vol 98, Num 8, pp 1275-1280, issn 1347-9032, 6 p.Article

  • Page / 1